AstraZeneca is throwing one last Hail Mary following a string of Big Pharma defeats challenging the legality of the Inflation ...

Even with Trump's looming threats to impose tariffs on pharma imports, the performance of AstraZeneca's cardiovascular and ...

Medically reviewed by Femi Aremu, PharmD Key Takeaways While both contain semaglutide, Wegovy is approved specifically for weight management, whereas Ozempic is approved for the treatment of type 2 ...

DelveInsight's SGLT2 Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

Under an expanded agreement with its customer argenx SE, a Belgian biopharmaceutical company, FUJIFILM will produce a drug ...

Are GLP-1 weight loss drugs the best we can do? Learn why some are pursuing alternatives to appetite suppression.

Lower eGFRs were associated with higher likelihood of developing kidney failure and death among adults with diabetes, ...

Pfizer enters the obesity drug market with its Metsera acquisition, aiming to challenge leaders Eli Lilly and Novo Nordisk.

Bagsværd, Denmark Saturday, September 20, 2025, 11:00 Hrs [IST] ...

FOR many, fat jabs have done a world of good – dulling hunger pangs and banishing maddening “food noise”, causing pounds to ...

NVO gains ground in the GLP-1 battle as Ozempic outshines Trulicity in heart risk reduction and Rybelsus wins EU approval for ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.